Table 1 Baseline characteristics in pharmacist consultation group and control group:
Variable | Pharmacist consultation group (N = 740) | Control group (N = 1476) | p-value |
|---|---|---|---|
Age (years, Mean; SD) | 70.0 ± 11.5 | 70.3 ± 11.6 | 0. 540 |
Female N (%) | 351 (47.4) | 698 (47.2) | 0.950 |
Socio-economic status score (Mean; SD) | 12.34 ± 17.5 | 12.5 ± 17.0 | 0.450 |
Chronic medications N (Mean; SD) | 11.4 ± 2.4 | 9.9 ± 2.4 | 0.001 |
DM (N, %) | 547 (73.9) | 1092 (73.9) | 0.973 |
HTN (N, %) | 648 (87.5) | 1329 (90.0) | 0.074 |
Dyslipidemia (N, %) | 645 (87.1) | 1261 (85.4) | 0.261 |
Homebound (N, %) | 117 (15.8) | 249 (16.8) | 0.524 |
HbA1c* (Mean; CI) | 7.21 ± 1.7 | 6.92 ± 1.3 | 0.001 |
SBP (mmHg)* (Mean; SD) | 134.9 ± 19.3 | 134.3 ± 17.1 | 0.433 |
DBP (mmHg)* (Mean; SD) | 68.2 + 25.1 | 75.50 ± 9.8 | 0.001 |
Total Cholesterol (mg/dl)* (Mean; SD) | 175.6 ± 44.4 | 168.7 ± 37.8 | 0.001 |
TG (mg/dl)* (Mean; SD) | 160.6 ± 87.9 | 156.0 ± 85.9 | 0.571 |
HDL Cholesterol (mg/dl) * (Mean; SD) | 45.6 ± 11.8 | 45.4 + 12.4 | 0.753 |
LDL Cholesterol (mg/dl)* (Mean; SD) | 98.7 ± 35.5 | 92.4 ± 31.1 | 0.001 |